J.-P. Van geertruyden  Clinical Microbiology and Infection 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Circumcision and penile human papillomavirus prevalence in human immunodeficiency virus-infected men: heterosexual and men who have sex with men  M.P.
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
O. Clerc, G. Greub  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Public health significance of invasive mosquitoes in Europe
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Prevalence of Toscana virus antibodies in residents of Croatia
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
Training for the infectious diseases speciality in Norway
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
Sexually acquired Zika virus: a systematic review
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
Reducing antibiotic use in influenza: challenges and rewards
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Clinical infection services—the Leiden experience
Influenza A(H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter  Epidemiological Task Group for Overseas.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Leishmaniasis in immunosuppressed individuals
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Interactions between malaria and human immunodeficiency virus anno 2014  J.-P. Van geertruyden  Clinical Microbiology and Infection  Volume 20, Issue 4, Pages 278-285 (April 2014) DOI: 10.1111/1469-0691.12597 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Clinical epidemiological impact of human immunodeficiency virus (HIV)–malaria interactions. Clinical Microbiology and Infection 2014 20, 278-285DOI: (10.1111/1469-0691.12597) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.